Novo Nordisk A/S (NVO): A Bull Case Theory
We came across a bullish thesis on Novo Nordisk A/S on The Analyst’s Journal’s Substack by A_Capital. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S’s share was trading at $56.72 as of October 15th. NVO’s trailing and forward P/E were 14.98 and 14.08, respectively according to Yahoo Finance. Novo Nordisk A/S represents a compelling long-term growth […]
The Stupidest Thing in American Health Care? Failing to Tackle Obesity Early.
It takes a very particular kind of political brainworm to look at a country where nearly half the population is obese, where Medicare and Medicaid hemorrhage cash treating diabetes, heart disease, stroke, and cancer — and say: let’s not pay for the medicine that actually fixes the root problem. And yet, here we are. GLP-1 […]
Semaglutide helps heart regardless of how much weight lost, study reveals
Anti-obesity medication semaglutide may help to prevent heart attacks and other major cardiac events regardless of how much weight people lose while taking the drug, according to a new study led by a UCL researcher.
SCIENCE: Study finds GLP-1 drugs may help prevent risks from sleep apnea.
SCIENCE: Study finds GLP-1 drugs may help prevent risks from sleep apnea.
GLP-1 Medications, Like Ozempic, May Help To Slow Or Even Reverse Aging According To New Study
Shutterstock GLP-1 drugs such as Ozempic have been shown to be extremely effective at helping diabetics manage their blood sugar, and almost anyone else to lose weight and keep it off. These drugs have also been shown to help stop addictions of all types in many people. A new study performed by TruDiagnostic has one […]
Why Everything From Perfume to Soap Smells Like Food Now
As demand for products scented like vanilla, pistachio and other edible indulgences soars, some GLP-1 users say there’s a link to their changed eating habits.
Among T2D Drugs, GLP-1s Top Others for Reducing CV Events
A comparative effectiveness study of glucose-lowering drugs finds the GLP-1 receptor agonists most protective against cardiovascular events, followed by SGLT2i and two older drug classes. Medscape Medical News
More and more workers are using weight loss drugs. It’s costing their employers a fortune – CNN
More and more workers are using weight loss drugs. It’s costing their employers a fortune CNN Ozempic for All The Atlantic Lopez: Expanding access to anti-obesity drugs a win-win Boston Herald What To Do When Insurance Won’t Cover Your GLP-1 Prescription NewBeauty Perspectives from Employers on the Costs and Issues Associated with Covering GLP-1 Agonists for Weight Loss KFF
Coke Is Leaning Into the Protein Craze as It Lands in More Drinks, Snacks—and Pet Foods
Beata Zawrzel / NurPhoto via Getty Images Coca-Cola is ramping up production of high-protein milks. Key Takeaways Coca-Cola is leaning into its high-protein milk products, but also planning to shake up the segment’s offerings as competition in the space heats up. Many food and beverage companies are focused on protein as a greater share of […]
GLP-1 Drugs Tied to Lower Risk of Legal Blindness in People With Diabetes
(MedPage Today) — ORLANDO — Adding another twist to the ongoing debate about the effects of weight-loss drugs on vision, a retrospective cohort study linked GLP-1 receptor agonists to a lower risk of legal blindness in patients with type 2…